0.62
-0.072(-10.48%)
Currency In USD
| Previous Close | 0.69 |
| Open | 0.62 |
| Day High | 0.63 |
| Day Low | 0.57 |
| 52-Week High | 9.3 |
| 52-Week Low | 0.57 |
| Volume | 968,289 |
| Average Volume | 925,273 |
| Market Cap | 2.84M |
| PE | -0.03 |
| EPS | -19.8 |
| Moving Average 50 Days | 2.58 |
| Moving Average 200 Days | 3.48 |
| Change | -0.07 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $375 as of December 25, 2025 at a share price of $0.615. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $127.86 as of December 25, 2025 at a share price of $0.615.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
GlobeNewswire Inc.
Dec 19, 2025 12:00 PM GMT
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call today at 10:00 a.m. ET UNIONDALE, NY, Dec. 19, 2025
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
GlobeNewswire Inc.
Nov 26, 2025 1:00 PM GMT
UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature ProPhase Lab’s Chai
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
GlobeNewswire Inc.
Nov 18, 2025 1:00 PM GMT
UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting third quarter 2025 fin